Gene Discovery News: Breaking Gene Discovery News, Comments and Articles. - Page: 5

05:30 EDT 26th October 2014 | BioPortfolio

Gene Discovery News - Page: 5RSS

Read the latest Gene Discovery News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Gene Discovery.

Search or Follow Our Gene Discovery - Page: 5 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Gene Discovery - Page: 5 News.

Showing "gene discovery" News Articles 101 to 125 of 7,400+

Wednesday 22nd October 2014

3rd Annual Cell Culture & Bioprocessing Congress, 17-18 November 2014, London. Registration Closing

The 3rd Annual <!--LGfEGNT2Lhm-->Cell Culture and Bioprocessing Congress will be taking place on the 17th and 18th of November 2014 in London. This congress is an executive platform for over 170 experts working in cell line development, cell line engineering, up and downstream operations, fermentation and biologics production. It features 4 interactive streams: Cell Line Development...

Finally: A missing link between vitamin D and prostate cancer

A University of Colorado Cancer Center study recently published in the journal Prostate offers compelling evidence that inflammation may be the link between Vitamin D and prostate cancer. Specifically, the study shows that the gene GDF-15, known to b...

Epigenetics Market worth $783.17 Million by 2019 - New Report by MarketandMarkets

The global epigenetics market is segmented into product segments of enzymes, instruments & consumables, kits, and reagents. http://www.marketsandmarkets.com/Market-Reports/epigenetics-technologies-market-896.html (PRWEB) October 22, 2014 The “Epigenetics Market by Product (Modifying Enzymes, DNA Polymerase, Acetylase, Methyltransferase, Instruments & Consumables, Kit, Bisulphite Convers...

New ALS associated gene identified using innovative strategy

Using an innovative exome sequencing strategy, a team of international scientists led by John Landers, PhD, at the University of Massachusetts Medical School has shown that TUBA4A, the gene encoding the Tubulin Alpha 4A protein, is associated with fa...

Bipolar disorder discovery at the nano level

A nano-sized discovery by Northwestern Medicine scientists helps explain how bipolar disorder affects the brain and could one day lead to new drug therapies to treat the mental illness.

Center for Predictive Medicine and Emerging Infectious Diseases Expands Biosafety Lab, Purchases Provantis SaaS

NIH Grant Helps University of Louisville Expand Facilities and Research Program Capabilities Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that The University of Louisville (UofL) Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases (CPM) has purchased thei...

Longer Looks: Obamacare In The Midterm Campaign; Watching Ebola Mutate; Lessons On Dying

Each week, KHN's Shefali Luthra finds interesting reads from around the Web. The Economist: Obamacare And The Midterms According to Kantar Media, a firm that tracks political advertising, health care is the main subject of campaign ads, especially Republican ones. Obamacare is unpopular—over half of Americans disapprove of it. Republicans talk about it constantly on the campaign trail, thoug...

TrueAllele Casework ruled admissible in Ohio Daubert challenge

-- Reliable Cybergenetics computer analysis of complex DNA aids conviction -- An Ohio judge ruled that TrueAllele® Casework is reliable under the Daubert admissibility standard. Judge Maureen Clancy also denied discovery of TrueAllele source code. The defendant Maurice Shaw accepted a guilty plea shortly after the Cleveland ruling. Cyb...

FDA Recommends Approval of KALYDECO®

Vertex Pharmaceuticals announced that the U.S. Food and Drug Administration’s Pulmonary Allergy Drugs Advisory Committee (PADAC) voted 13-2 to recommend approval of KALYDECO® (ivacaftor) in people with cystic fibrosis (CF) ages 6 and older who hav...

Glaucoma Foundation Holds Third Scientific Think Tank On Exfoliation Syndrome

NEW YORK, Oct. 22, 2014 /PRNewswire-USNewswire/ -- The Glaucoma Foundation's recently concluded 2014 International Scientific Think Tank was TGF's third consecutive annual gathering to focus on exfoliation syndrome (XFS), an age-related systemic disease characterized by the production and accumulation of a whitish material in many ocular as well as non-ocular tissues. Three years ago TG...

FDA advisory backs expanded use of Vertex’ CF drug

There was good news for US biotech firm Vertex Pharmaceuticals yesterday, as a US Food and Drug Administration advisory committee 13 to two to recommend approval of Kalydeco (ivacaftor) in cystic fibrosis (CF) patients aged six and older who have the...

Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China

Collaboration to address needs of biopharmaceutical companies conducting clinical R&D in China Foundation Medicine, Inc. (NASDAQ:FMI) and WuXi PharmaTech (Cayman) Inc. (NYSE:WX) today announced a collaboration to offer Foundation Medicine’s comprehensive

Hanson Wade Release: Upcoming World Antibody-Drug Conjugate (ADC) Meeting and Awards in San Diego Highlight California's Growing Cancer Therapeutics Hub

SAN DIEGO, Calif., Oct. 21, 2014 /PRNewswire-iReach/ -- Antibody-drug conjugates (ADCs) are one of the most exciting new classes of cancer therapeutics because they combine the potency of small molecules with the specificity of antibodies. California's culture of innovation, as well as access to world class drug discovery and development expertise, has accelerated progress in ADC therapeutics, a m...

Researchers Use ScreenCell® To Enrich Breast Cancer CTC Biomarkers

ScreenCell has entered into a collaborative study with the Jefferson Breast Care Center at the Sidney Kimmel Cancer Center of Thomas Jefferson University in Philadelphia, to evaluate the effectiveness of ScreenCell's proprietary devices and protocols for enrichment of Circulating Tumor Cells (CTCs) from peripheral blood. ScreenCell technology separates CTC...

Acceleron Announces Educational Webcast on Chronic Kidney Disease - Mineral and Bone Disorder

Prominent nephrologist, Ravi Thadhani, M.D., M.P.H. to lead third seminar in Acceleron series Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today announced it will host and webcast an online education...

Compugen Third Quarter 2014 Conference Call Scheduled for Wednesday, October 29, 2014 at 10:00 AM ET

Compugen Ltd. (NASDAQ: CGEN) today announced that the Company will host a conference call at 10:00 AM ET on Wednesday, October 29, 2014 to review third quarter 2014 results. The quarterly results will be released on the Company’s website (www.cgen.com), prior to the conference call. To access the conference call,

FDA panel backs wider use of Vertex cystic fibrosis drug

More cystic fibrosis patients in the US should be eligible for treatment with Vertex Pharma's Kalydeco therapy, according to an FDA advisory committee.Yesterday the expert panel voted 13 to two in favour of extending the indications of Kalydeco (ivac...

Biogen Idec Third Quarter 2014 Revenues Increase 37% to $2.5 Billion

PLEGRIDYTM Approved in the US and EU for Multiple Sclerosis ELOCTATETM Launched in the US for Hemophilia A Rollout of TECFIDERA® Continues across the Globe Biogen Idec Inc. (NASDAQ: BIIB) today reported third quarter 2014 results, including revenue of $2.5 billion, a 37% increase compared to the third quarter of ...

Innocrin Pharmaceuticals Created as a Spin-out of the Prostate Cancer Program from Viamet Pharmaceuticals

Will Focus on Clinical Development of Best in Class Dual CYP17 Lyase Inhibitor / Androgen Receptor (AR) Antagonist Innocrin Pharmaceuticals, Inc., (www.innocrinpharma.com), a privately held pharmaceutical company that focuses on the discovery and development of best-in-class, small molecule CYP17 lyase inhibitors, announced today its formation as a spi...

Improvements to DNA Testing Can Help Treat And Prevent Childhood Blindness

Expert ophthalmologists at Beverly Hills Medical Center in Kuwait comment on new developments in DNA testing for congenital cataracts. Kuwait (PRWEB) October 22, 2014 A new research study out of the United Kingdom has found that advancements in gene-sequencing technology can help ophthalmologists identify mutations that often lead to childhood blindness. According to the new study published onl...

Regulus Therapeutics demonstrates human proof-of-concept with microRNA therapeutic

Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it has demonstrated human proof-of-concept with a microRNA therapeutic from a...

New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies

BASKING RIDGE, N.J., Oct. 22, 2014 /PRNewswire/ -- Reproductive Medicine Associates of New Jersey (RMANJ), a world-renowned leader in the field of infertility, presents new clinical research examining a more rapid approach to embryonic screening. The research abstract, released during the 70th annual American Society for Reproductive Medicine (ASRM) meeting in Honolulu, Hawaii, combines compr...

Biomarker Discovery Company, Antigen Discovery Inc., Awarded an NIH Phase I Small Business Innovation Research Grant to Develop a Pan-HIV Protein Microarray Chip

IRVINE, Calif., Oct 22, 2014 /PRNewswire/ -- Antigen Discovery Inc. (ADi), a privately held company in Irvine, California, announced the receipt of a National Institutes of Health (NIH) Phase I Small Business Innovation Research award (SBIR) from the National Institute of Dental and Craniofacial Research (NIDCR). The one-year $225,000 award will fund the development of a Pan-HIV Protein ...

MedAptus and Entrada Announce Corporate Partnership

BOSTON, Oct. 22, 2014 /PRNewswire/ -- Entrada and MedAptus® today announced a formal partnership to integrate Entrada's technology and services within the MedAptus Pro Charge Capture solution. MedAptus, a leading revenue cycle and charge management company, will deploy Entrada's dictation recording tools directly within its mobile application to complement the pro fee coding process, enabling...

Medical Diagnostic Laboratories, L.L.C. Institute for Biomarker Research Announces New Prenatal Cystic Fibrosis Tests

HAMILTON, N.J., Oct. 22, 2014 /PRNewswire/ -- Medical Diagnostic Laboratories, L.L.C., (MDL), a CLIA-certified, CAP-accredited laboratory which specializes in high complexity, state-of-the-art, automated DNA-based molecular analyses, announces that it is now offering new Cystic Fibrosis Testing which utilizes cutting edge technology, including next- generation DNA sequencing platforms. Cysti...


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks